The Clinical Guidelines Program is a longstanding, collaborative effort of the New York State Department of Health (NYSDOH) AIDS Institute (AI), Office of the Medical Director (OMD), and the Johns Hopkins University (JHU) School of Medicine, Division of Infectious Diseases.
Mission: To develop and disseminate practical, evidence-based clinical guidelines that promote quality medical care for people in New York who are living with and/or are at risk of acquiring HIV, HCV, STIs and substance use.
Expert committees: AIDS Institute clinical guidelines are developed by committees of expert New York State clinicians. Committee members collaborate to survey and evaluate peer-reviewed literature, write and assess clinical recommendations, and update existing guidelines or create new guidelines as necessary to ensure that recommendations reflect current best practices. All new and revised guidelines undergo peer and consumer review.
Evidence-based recommendations: Committee members apply their expertise and experience in evaluating factors that determine treatment decisions, including potential benefits and outcomes, risks, and burdens to the patient; patient views, values, and preferences; feasibility and tolerability; and the quality of evidence supporting a treatment recommendation. All recommendations are assigned ratings based on the strength and quality of the supporting evidence.
Audience: AIDS Institute clinical care guidelines are produced and disseminated to clinicians in New York who provide prevention services and medical care to people who are living with or at risk of acquiring HIV, HCV, STIs and substance use.
Stay Up-To-Date with the Clinical Guidelines Program: Subscribe to Topics, Trends & Updates to receive an email announcement when new guidelines or updates to guidelines are published, along with highlights from hot topics and events, and trends in guideline use. Subscribe now
Let Us Know What You Think: Complete our brief survey to give feedback on the guidelines and the website. Complete the survey now
- Topics, Trends & Updates (7/9/20)
- New Guideline: Post-Exposure Prophylaxis (PEP) to Prevent HIV Infection (6/25/20)
- Medscape Commentary: PrEP Is Highly Effective; How Can We Increase Adoption? (6/25/20)
- Update: Universal Screening for HCV Now Recommended (6/9/20)
- Resource: Recommended Dose Adjustments for Use of Selected Fixed-Dose Combination ARVs in Patients with Hepatic or Renal Impairment (5/18/20)
- Updated Guideline: Screening for Anal Dysplasia and Cancer in Patients with HIV (3/18/20)
- New Pocket Guide: Screening for Anal Dysplasia and Cancer in Patients with HIV (3/18/20)
- Guideline Update: PrEP to Prevent HIV and Promote Sexual Health (2/10/20)
- FDA MedWatch: Certain COVID-19 Serology/Antibody Tests Should Not Be Used - Letter to Clinical Laboratory Staff and Health Care Providers (6/24/20)
- NYC DOHMH: Dear Colleague COVID-19 Updates, Health Inequities and COVID-19 (6/23/20)
- NYC Health: COVID-19 Prevention and Groups at Higher Risk (6/11/20)
- CDC: What to Know About HIV and COVID-19 (6/4/20)
- NASTAD: Accountability as a Public Health Response: COVID-19’s Impact on Communities of Color (6/4/20)
Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression: Many clinicians provide care for patients who struggle with taking enough of their antiretroviral therapy (ART) to maintain a consistently undetectable viral load . . . Read more
Persistence of Association Between HIV and Risk of Atherosclerotic Cardiovascular Disease: People with HIV are at increased risk for atherosclerotic cardiovascular disease (ASCVD), including myocardial infarction (MI) and stroke . . . Read more
- 8/09/20: HRSA: 2020 Ryan White HIV/AIDS Program (RWHAP) Clinical Conference (Virtual)
- 8/11/20: HRSA: 2020 National Ryan White Conference on HIV Care & Treatment (Virtual)
- 8/20/20: ACTHIV 2020 (Virtual)
- 9/08/20: HealthHIV: SYNChronicity 2020 Conference (Virtual)
- 9/14/20: CDC: 2020 STD Prevention Conference (Virtual)
- 7/15/20: CEI This Month in HIV: HIV Prevention Updates
- 7/16/20: MA AETC: COVID-19 and HIV Series: Substance Use and Harm Reduction During COVID-19
- 7/20/20: MWAETC: Telemedicine Series: Session #5 - Clinical Best Practices for Telemedicine
- 7/21/20: NEAETC: IAS Update 2020
- 7/22/20: CEI DUH ECHO: Preventing Drug Overdose